ZBH | tickerfilter.com

Fundamental analysis

55%

Profitability 39%

Dept financing 44%

Liquidity 15%

Performance 83%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-2.78%

1 Month

7.01%

3 Months

0.67%

6 Months

0.13%

1 Year

-14.44%

2 Year

-15.05%

Key data

Stock price

$107.57

P/E Ratio

23.31

DAY RANGE

$104.10 - $107.74

EPS

$4.13

52 WEEK RANGE

$97.69 - $133.90

52 WEEK CHANGE

-$14.06

MARKET CAP

21.028 B

YIELD

0.91%

SHARES OUTSTANDING

203.652 M

DIVIDEND

$0.24

EX-DIVIDEND DATE

06-26-2024

NEXT EARNINGS DATE

N/A

BETA

0.45

PUBLIC FLOAT

AVERAGE 10 VOLUME

$2,058,494

AVERAGE 30 VOLUME

$1,981,034

Company detail

CEO: Bryan C. Hanson
Region: US
Website: zimmerbiomet.com
Employees: 18,000
IPO year: 2001

Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Zimmer Biomet Holdings, Inc. operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products.

ZBH - ZIMMER BIOMET HOLDINGS, INC.